These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
394 related items for PubMed ID: 27745996
1. Neurovascular bundle-sparing radiotherapy for prostate cancer using MRI-CT registration: A dosimetric feasibility study. Cassidy RJ, Yang X, Liu T, Thomas M, Nour SG, Jani AB. Med Dosim; ; 41(4):339-343. PubMed ID: 27745996 [Abstract] [Full Text] [Related]
2. Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function. Hwang ME, Mayeda M, Shaish H, Elliston CD, Spina CS, Wenske S, Deutsch I. Br J Radiol; 2021 Mar 01; 94(1119):20200433. PubMed ID: 33586999 [Abstract] [Full Text] [Related]
3. Dominant intraprostatic lesion boosting in sexual-sparing radiotherapy of prostate cancer: A planning feasibility study. Ciabatti S, Ntreta M, Buwenge M, Gaudiano C, Sessagesimi E, Romani F, Angelini AL, Cammelli S, Macchia G, Deodato F, Zamagni A, Golfieri R, Morganti AG, Cilla S. Med Dosim; 2021 Mar 01; 44(4):356-364. PubMed ID: 30955990 [Abstract] [Full Text] [Related]
4. Dose painting to treat single-lobe prostate cancer with hypofractionated high-dose radiation using targeted external beam radiation: Is it feasible? Amini A, Westerly DC, Waxweiler TV, Ryan N, Raben D. Med Dosim; 2015 Mar 01; 40(3):256-61. PubMed ID: 25824420 [Abstract] [Full Text] [Related]
5. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy. Myrehaug S, Chan G, Craig T, Weinberg V, Cheng C, Roach M, Cheung P, Sahgal A. Int J Radiat Oncol Biol Phys; 2012 Mar 15; 82(4):e657-62. PubMed ID: 22245189 [Abstract] [Full Text] [Related]
6. A dosimetric comparison of tomotherapy and volumetric modulated arc therapy in the treatment of high-risk prostate cancer with pelvic nodal radiation therapy. Pasquier D, Cavillon F, Lacornerie T, Touzeau C, Tresch E, Lartigau E. Int J Radiat Oncol Biol Phys; 2013 Feb 01; 85(2):549-54. PubMed ID: 22677369 [Abstract] [Full Text] [Related]
10. Dosimetric effects of the prone and supine positions on image guided localized prostate cancer radiotherapy. Liu B, Lerma FA, Patel S, Amin P, Feng Y, Yi BY, Yu C. Radiother Oncol; 2008 Jul 01; 88(1):67-76. PubMed ID: 18207595 [Abstract] [Full Text] [Related]
13. IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI. van Lin EN, Fütterer JJ, Heijmink SW, van der Vight LP, Hoffmann AL, van Kollenburg P, Huisman HJ, Scheenen TW, Witjes JA, Leer JW, Barentsz JO, Visser AG. Int J Radiat Oncol Biol Phys; 2006 May 01; 65(1):291-303. PubMed ID: 16618584 [Abstract] [Full Text] [Related]
14. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate. Battista JJ, Johnson C, Turnbull D, Kempe J, Bzdusek K, Van Dyk J, Bauman G. Int J Radiat Oncol Biol Phys; 2013 Dec 01; 87(5):874-80. PubMed ID: 23978708 [Abstract] [Full Text] [Related]
17. A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes. Song DY, Herfarth KK, Uhl M, Eble MJ, Pinkawa M, van Triest B, Kalisvaart R, Weber DC, Miralbell R, Deweese TL, Ford EC. Int J Radiat Oncol Biol Phys; 2013 Sep 01; 87(1):81-7. PubMed ID: 23414766 [Abstract] [Full Text] [Related]
18. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy. Georg D, Hopfgartner J, Gòra J, Kuess P, Kragl G, Berger D, Hegazy N, Goldner G, Georg P. Int J Radiat Oncol Biol Phys; 2014 Mar 01; 88(3):715-22. PubMed ID: 24521685 [Abstract] [Full Text] [Related]